Suppliers / Exemed Pharmaceuticals

Exemed Pharmaceuticals

India 459 employees Updated 9 July 2026

Exemed Pharmaceuticals is an API and finished-dose manufacturer based in India. It holds 7 active US drug master files and 4 valid CEPs across a filed portfolio of 7 molecules. Its filings concentrate with CDSCO (India), ARCSA (EC) and RAMA (GE). Its GMP standing is certified by CDSCO (India), EMA and US FDA, among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 13 September 2024 as VAI. Customs aggregates show $10.9M of exports covering 294 molecules to 43 destinations in 2025.

7
active US DMFs
4
valid CEPs
7
registered plants 1 with an FDA FEI number
113
filings across 6 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 13 September 2024 VAI US FDA
  • 10 December 2013 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
tal padra padra 391 440 vadodara, India Not on file
vapi, India Not on file
Plot No., India Not on file
vapi 396 195 valsad, India Not on file
vapi 396 195valsad, India Not on file
tal padrapadra 391 440vadodara, India Not on file

1 further sites are on record.

What they file, and where

Molecule Regulators Docs
Metformin EDQM, SFDA (Saudi Arabia), US FDA 4
Allopurinol EDQM, US FDA 2
Dextromethorphan EDQM, US FDA 2
Sertraline US FDA 2
Levetiracetam EDQM 1
Sacubitril US FDA 1
Vildagliptin US FDA 1

Also appears on these molecule pages

Allopurinol API Bempedoic Acid finished dose Bilastine finished dose Brivaracetam finished dose Carvedilol finished dose Clopidogrel finished dose Dapagliflozin finished dose Dapagliflozin Propanediol finished dose Dextromethorphan API Elagolix finished dose Empagliflozin finished dose Fexofenadine finished dose
Show 18 more molecule pages
Gliclazide finished dose Itraconazole finished dose Levetiracetam API Linagliptin finished dose Metformin API Molnupiravir finished dose Pioglitazone finished dose Plecanatide finished dose Rivaroxaban finished dose Sacubitril API Saxagliptin finished dose Sertraline API Tedizolid finished dose Ticagrelor finished dose Torasemide finished dose Vildagliptin API Vonoprazan finished dose Voriconazole finished dose

Filings and GMP by regulator

Regulator Filings GMP certificates
CDSCO (India) 58 6
ARCSA (EC) 29 None
RAMA (GE) 15 None
DIGEMAPS (DO) 5 None
MINSA (CR) 3 None
UZPHARM (UZ) 3 1
EMA None 4
US FDA None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $2.3M 17
2025 Not reported $10.9M 43
2024 Not reported $10.3M 35
2023 Not reported $9.5M 40

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Exemed Pharmaceuticals

Does Exemed Pharmaceuticals hold a US DMF or a CEP?
Exemed Pharmaceuticals holds 7 active US drug master files and 4 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Exemed Pharmaceuticals FDA-registered?
One site operated by Exemed Pharmaceuticals carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Exemed Pharmaceuticals's last inspection go?
The most recent inspection on record closed on 13 September 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 2 inspections are on file.
Where does Exemed Pharmaceuticals manufacture?
7 registered sites are on record, in India (Tal Padra Padra 391 440 Vadodara, Vapi and Plot No. among others). Every site is listed on this page with the register it came from.
What does Exemed Pharmaceuticals make?
7 molecules are on record against Exemed Pharmaceuticals, including Metformin, Allopurinol, Dextromethorphan and Sertraline. Each links through to that molecule's full manufacturer list.
Which regulators recognise Exemed Pharmaceuticals's GMP?
Current GMP certificates are on record from CDSCO (India), EMA, US FDA and UZPHARM (UZ). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Exemed Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 13 September 2024.

Comparable suppliers

Harman Finochem shares 4 molecules Apitoria Pharma shares 3 molecules Hetero shares 3 molecules Dr Reddy's Laboratories shares 3 molecules Ipca Laboratories shares 3 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts